Scott Blumberg - 18 Aug 2026 Form 4 Insider Report for Ceribell, Inc. (CBLL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Aug 2026, 20:55:25 UTC
Prior SEC filing
26 May 2026
Next SEC filing
25 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Louisa Daniels, Attorney-in-Fact for Scott Blumberg

Key filing fact

Scott Blumberg filed Form 4 for Ceribell, Inc. (CBLL) on 20 Aug 2026.

Key facts

  • This page summarizes Scott Blumberg's Form 4 filing for Ceribell, Inc. (CBLL).
  • 10 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2026, 20:55.

Change

  • Previous filing in this sequence was filed on 26 May 2026.
  • Current net transaction value: -$863,555.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002035786 Primary reporting owner

Blumberg Scott

Relationship
Chief Financial Officer
Address
C/O CERIBELL, INC., 360 N. PASTORIA AVENUE, SUNNYVALE
Signature
/s/ Louisa Daniels, Attorney-in-Fact for Scott Blumberg
Signature date
20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CBLL transaction

Common Stock

Options Exercise

Transaction value
Shares
+690
Change %
+0.47%
Price
$4.70*
Shares after
148,811
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1, F2
CBLL transaction

Common Stock

Options Exercise

Transaction value
Shares
+300
Change %
+0.2%
Price
$9.41*
Shares after
149,111
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1
CBLL transaction

Common Stock

Sale

Transaction value
$24,750
Shares
-990
Change %
-0.66%
Price
$25.00
Shares after
148,121
Date
18 Aug 2026
Ownership
Direct
Footnotes
F1
CBLL transaction

Common Stock

Options Exercise

Transaction value
Shares
+6,179
Change %
+4.2%
Price
$4.70*
Shares after
154,300
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1
CBLL transaction

Common Stock

Options Exercise

Transaction value
Shares
+27,333
Change %
+18%
Price
$9.41*
Shares after
181,633
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1
CBLL transaction

Common Stock

Sale

Transaction value
$838,805
Shares
-33,512
Change %
-18%
Price
$25.03
Shares after
148,121
Date
19 Aug 2026
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CBLL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-690
Change %
-1.6%
Price
$0.000000*
Shares after
43,403
Date
18 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
690
Exercise price
$4.70
Footnotes
F1, F4
CBLL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-300
Change %
-0.37%
Price
$0.000000*
Shares after
80,633
Date
18 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300
Exercise price
$9.41
Footnotes
F1, F5
CBLL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-6,179
Change %
-14%
Price
$0.000000*
Shares after
37,224
Date
19 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,179
Exercise price
$4.70
Footnotes
F1, F4
CBLL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-27,333
Change %
-34%
Price
$0.000000*
Shares after
53,300
Date
19 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,333
Exercise price
$9.41
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

Footnote F2

Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.

Footnote F4

The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Footnote F5

The stock option is fully vested and currently exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .